Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Metastatic Rectal Cancer”

289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 289 results

Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Early research (Phase 1)Study completedNCT05954871
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerNon-Small Cell Lung Cancer
Genentech, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT05799820
What this trial is testing

QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRC

Who this might be right for
Colorectal Carcinoma
Qilu Pharmaceutical Co., Ltd. 60
Early research (Phase 1)Looking for participantsNCT06853496
What this trial is testing

Study of a Tankyrase Inhibitor RK-582 for Patients With Unresectable Metastatic Colorectal Cancer

Who this might be right for
Unresectable Colorectal Neoplasm Metastasis
Eiji Shinozaki 48
Early research (Phase 1)Study completedNCT00001576
What this trial is testing

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Who this might be right for
Colorectal NeoplasmLiver NeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Ended earlyNCT02842580
What this trial is testing

De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 21
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Looking for participantsNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Early research (Phase 1)Looking for participantsNCT07066657
What this trial is testing

MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more
ArriVent BioPharma, Inc. 405
Testing effectiveness (Phase 2)Study completedNCT04513951
What this trial is testing

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 62
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07009145
What this trial is testing

QL1706 Plus Bevacizumab for Unresectable or Metastatic MSI-H/dMMR CRC

Who this might be right for
Unresectable Colorectal CancerMetastatic Colorectal Cancer (CRC)MSI-H/dMMR Colorectal Cancer
Qianfoshan Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Not applicableLooking for participantsNCT05185245
What this trial is testing

Liver Transplantation for Non-Resectable Colorectal Liver Metastasis

Who this might be right for
Liver Metastasis Colon CancerColorectal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)WithdrawnNCT00388700
What this trial is testing

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Galectin Therapeutics Inc.
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT02218801
What this trial is testing

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

Who this might be right for
Liver MetastasisColorectal Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 219
Load More Results